fda drug shortage semaglutide ends as sets deadline for compounders Off-brand versions of Ozempic, Wegovy

Here's the definitive quick reference: SIGNATURE TOXICITIES & ANTIDOTES: Cyclophosphamide = Hemorrhagic Cystitis MESNA (2-Mercaptoethane Sulfonate) Methotrexate = Myelosuppression Leucovorin (Folinic Acid) Rescue Doxorubicin = Cardiotoxicity Dexrazoxane (Cardioprotective) Cisplatin = Nephrotoxicity, Ototoxicity Amifostine (Cytoprotective) Bleomycin = Pulmonary Fibrosis (No antidote Prevention) Vincristine = Peripheral Neuropathy (No antidote Dose limiting) 5-FU = Palmar-Plantar Erythrodysesthesia (Hand-Foot Syndrome) CLASSIFICATION: Cell Cycle Specific: MTX (S), 5-FU (S), Vinca alkaloids (M), Taxanes (M) Cell Cycle Non-Specific: Cyclophosphamide, Doxorubicin, Cisplatin Mnemonic: "MESNA = Makes Cyclophosphamide Safe (NA)" One topic

ForePass is now advancing toward first-in-human clinical studies

This guide breaks down exact shelf life for each major peptide category, what factors affect longevity, how to recognize degradation, optimal storage practices, and when to mix fresh batches

Before administering any reconstituted injectable medicine, a careful visual inspection must always be performed

Introduction Today, GLP-1 drugs are most commonly used for diabetes and weight loss, but there is potential for GLP-1 therapies to transform healthcare by offering new solutions for managing chronic conditions